Why the study?
Atherosclerotic volume is a risk factor for future stroke that needs noninvasive measurement, as stenosis severity alone may not adequately identify risk in asymptomatic carotid stenosis.
Does tomographic ultrasound accurately measure carotid plaque volume compared to endarterectomy specimen volume in patients undergoing CEA?
Does tomographic ultrasound accurately measure carotid plaque volume compared to endarterectomy specimen volume in patients undergoing CEA?
Tomographic ultrasound accurately measures carotid plaque volume, with contrast enhancement providing slight improvements for research precision, while unenhanced tUS is sufficient for screening.
Tomographic ultrasound may accurately measure carotid plaque volume; hypothesis-generating for clinical use pending prospective validation.
Background Stenosis severity has been the indication for carotid endarterectomy (CEA) for 4 decades, but the annual stroke risk in asymptomatic carotid stenosis >70% is under 2%. Atherosclerotic volume has emerged as a risk factor for future stroke, but needs to be measured noninvasively. Tomographic ultrasound (tUS) is a novel technology that assembles 3D images in seconds. We evaluated accuracy of measuring Carotid Plaque Volume (CPV) with tUS in patients undergoing CEA. Method Consecutive patients were imaged immediately before CEA by tUS and contrast-enhanced tUS (CEtUS). CPV was measured using tUS, CEtUS, and a fused images incorporating both tUS and CEtUS by trained vascular scientists. Precise volume of the endarterectomy specimen was measured using Archimedes technique. Results Mean ± sd (range) CPV in 129 endarterectomy specimens was 0.75 ± 0.43 cm 3 (0.10–2.47 cm 3 ). Mean ± sd CPV measured by tUS ( n = 114) was 0.87 ± 0.51 cm 3 , CEtUS ( n = 104) was 0.75 ± 0.45 cm 3 and with fusion ( n = 95) was 0.83 ± 0.49 cm 3 . Differences between specimen volume and CPV measured by tUS (0.13 ± 0.24 cm 3 ), CEtUS (−0.01 ± 0.21 cm 3 ) or fusion (−0.08 ± 0.20) were clinically insignificant. Intra-/interobserver differences were minimal. Conclusions tUS accurately measures CPV with excellent intra-/interobserver agreement. CEtUS improves accuracy if precise CPV measurement is needed for research but tUS alone would be sufficient for population screening.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: